HR Execs on the Move

Advanced Cardiac Therapeutics Inc

www.actmed.net

 
Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company`s mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system. ACT`s technology is the only system in the world to leverage feedback from four unique capabilities: temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing. The ACT ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.actmed.net
  • 1278 Glenneyre Suite 139
    Laguna Beach, CA USA 92651
  • Phone: 949.500.0192

Executives

Name Title Contact Details

Similar Companies

Mortara Instrument

Founded in 1982 by David W. Mortara, PhD, Mortara Instrument was born with a guiding philosophy: design to a need, keep it simple, and make it economically accessible. Building on this philosophy, Mortara Instrument has created a complete line of

Direct Supply

Direct Supply offers nearly 1 million essential products for healthcare, foodservice, environmental and furnishings, and theyre all eldercare approved.

Wave Form Systems Inc

Wave Form Systems Inc is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monteris Medical

Monteris Medical is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Insulet

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnpod technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 100,000 users across the globe rely on Insulet`s Omnipod Insulin Management System to bring simplicity and freedom to their lives. For more information, please visit: www.insulet.com, www.myomnipod.com and https://www.omnipodeurope.com.* *Starting July 1, 2018, Insulet will assume direct distribution of its Omnipod Insulin Management System in Europe, including sales, marketing, training and customer support activities. This will allow Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long term, as it already does in the United States and Canada.